Found 28 matching trials
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma PHASE1 This is a single-center, non-randomized study to evaluate the safety and ef...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma EARLY_PHASE1 The goal of this clinical trial is to study the feasibility and efficacy of...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM EARLY_PHASE1 This study is a single-arm, open-label, dose-escalation trial to explore th...
Show More Status
Active Not Recruiting
Location
Shanghai Changzheng Hospital
Learn More & Join Trial
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma PHASE1 This is a single-center, non-randomized and dose-escalation study to evalua...
Show More Learn More & Join Trial
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of this study is to determine if UF-KURE-BCMA (B-Cell Maturatio...
Show More Location
University Hospitals Cleveland Medical Center Seidman Cancer Center
Learn More & Join Trial
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus PHASE1 study evaluates a biomarker-guided strategy to assign adults with refractor...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Anti-BCMA CAR T-Cell Therapy for R/R ITP PHASE2 This is a prospective, single-center, open-label, single-arm study, to eval...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma PHASE1 This is an open-label study to determine the safety of anti-B-cell maturati...
Show More Status
Active Not Recruiting
Location
University of California, San Francisco
Learn More & Join Trial